Comparative study on the in vitro effectiveness of antithrombotic agents

This publication has 11 references indexed in Scilit:

• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
  Journal of Clinical Investigation, 1990
• Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina
  The Lancet, 1990
• The effect of FUT-175 (nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo
  International Journal of Immunopharmacology, 1990
• Contribution of the N-terminal region of hirudin to its interaction with thrombin
  Biochemistry, 1989
• Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis
  Blood, 1989
• Effects of an antithrombotic agent (MD-805) on progressing cerebral thrombosis
  Thrombosis Research, 1989
• Clinico-pharmacological studies with recombinant hirudin
  Thrombosis Research, 1988
• Kinetics of the inhibition of thrombin by hirudin
  Biochemistry, 1986
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• The Determination of Enzyme Dissociation Constants
  Journal of the American Chemical Society, 1934